A drug used to treat Type 2 diabetes and obesity could also slow down the process of ageing, researchers believe.
Semaglutide, better known as Ozempic, "has far-reaching benefits beyond what we initially imagined," Prof Harlan Krumholz, from the Yale School of Medicine, said following the publication of several new studies.
They found that the drug could be used to treat a wide range of illnesses linked to heart failure, arthritis, Alzheimer’s and even cancer.
The new data has been published in a number of medical journals, including the Journal of the American College of Cardiology (JACC), which Prof Krumholz edits.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#Ozempic #BBCNews
Napoli, 31/01/2026 - Il Sottosegretario alla Presidenza del Consiglio, Alfredo Mantovano, interviene all'inaugurazione dell’Anno Giudiziario 2026 nel Distretto della Corte…
ROMA (ITALPRESS) – “Quando ci lamentiamo del fatto che gli americani vogliono diminuire la loro presenza, e dunque la loro…